Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 4 Small Cell Lung Carcinoma 2 Breast Neoplasms 2 Pancreatic Neoplasms 1 Pancreatic Cancer Metastatic 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lung Neoplasms 1 Gliosarcoma 1 Glioma 1 Chondrosarcoma 1 Cholangiocarcinoma 1 Carcinoma, Intraductal, Noninfiltrating 1 Brain Neoplasms 1 Arthritis, Rheumatoid 1

Interventions

pembrolizumab 155 Gemcitabine 139 Capecitabine 121 Paclitaxel 118 Fluorouracil 116 Oxaliplatin 110 Bevacizumab 104 Nivolumab 97 Leucovorin 97 Docetaxel 92 Cisplatin 89 Irinotecan 87 Carboplatin 84 Radiosurgery 83 Cyclophosphamide 70 Cetuximab 70 Magnetic Resonance Spectroscopy 68 Trastuzumab 56 Specimen Handling 56 Biopsy 56 Radiotherapy 55 Ipilimumab 52 Everolimus 48 Pemetrexed 46 Drug Therapy 45 Albumin-Bound Paclitaxel 44 130-nm albumin-bound paclitaxel 43 Doxorubicin 41 Fulvestrant 38 aldesleukin 37

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neoplasm Metastasis × Chloroquine × Clear all

NCT01894633 2024-01-24

CLQ

Instituto Nacional de Cancerologia de Mexico

Phase 2 Terminated

Brain Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡